Agreement signedPublished 24 Aug 2026

Skye Bioscience, Inc. /
Redx Pharma Limited

Skye Bioscience, Inc. signed an agreement for Redx Pharma Limited.

Buy side: Skye Bioscience, Inc.
Buy sideSkye Bioscience, Inc.
Target: Redx Pharma Limited
TargetRedx Pharma Limited
Skye Bioscience, Inc. · 24 Aug 2026Source
Buy side: Skye Bioscience, Inc.
Buy sideSkye Bioscience, Inc.
Target: Redx Pharma Limited
TargetRedx Pharma Limited
01 / BuyerSkye Bioscience, Inc.
02 / TargetRedx Pharma Limited
Source for the buyer and target: Skye Bioscience, Inc.

For the buyer and target.

“In connection with the proposed acquisition of Redx Pharma Limited (“Redx”) by Skye Bioscience, Inc. (“Skye” or the “Company”) (the “Transaction”), the Company intends to file with the U.S. Securities and Exchange Commission (the “SEC”) a proxy statement (the “Proxy Statement”), the definitive version of which will be sent or provided to the Company’s stockholders.”

Published 24 Aug 2026

Open the source
01

What happened

The deal for Redx Pharma Limited is signed, with Skye Bioscience, Inc. as the buyer. [01]

The filing from Skye Bioscience, Inc. is dated Aug. 24, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Skye Bioscience, Inc.

Skye Bioscience, Inc. signed an agreement for Redx Pharma Limited.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    “The filing from Skye Bioscience, Inc. is dated Aug. 24, 2026”

    Open the source
  2. Published by Skye Bioscience, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.